Sigilon Therapeutics, Inc. Net Profit Margin 2021-2023 | SGTX
Sigilon Therapeutics, Inc. net profit margin from 2021 to 2023. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2023-06-30 | $0.02B | $-0.03B | -172.22% |
| 2023-03-31 | $0.02B | $-0.04B | -246.67% |
| 2022-12-31 | $0.01B | $-0.04B | -338.46% |
| 2022-09-30 | $0.01B | $-0.06B | -458.33% |
| 2022-06-30 | $0.01B | $-0.07B | -660.00% |
| 2022-03-31 | $0.01B | $-0.07B | -720.00% |
| 2021-12-31 | $0.01B | $-0.08B | -770.00% |
| 2021-09-30 | $0.01B | $-0.07B | -616.67% |
| 2021-06-30 | $0.01B | $-0.07B | -478.57% |
| 2021-03-31 | $0.01B | $-0.06B | -461.54% |
| 2020-12-31 | $0.01B | $-0.05B | -415.38% |
